Published in

BMJ Publishing Group, Tobacco Control, 3(27), p. 347-351, 2017

DOI: 10.1136/tobaccocontrol-2017-053634

Links

Tools

Export citation

Search in Google Scholar

Implications and challenges for implementation of the FDA’s final deeming rule for waterpipe tobacco

Journal article published in 2017 by Erin L. Sutfin, Eric K. Soule, Karma McKelvey, Desmond Jenson ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

For the first time, the Food and Drug Administration’s (FDAs) Center for Tobacco Products now has regulatory authority over all tobacco products, including waterpipe tobacco. In the rule expanding its authority to cover all tobacco products, the FDA uses largely a one-size-fits-all approach. However, several aspects of waterpipe tobacco smoking make it unique from other tobacco products, which may require more specific, tailored rules. This paper describes the distinct features of waterpipe tobacco products and accessories, and identifies unique challenges to the current regulation posed by this form of tobacco use. Additionally, we highlight the need for further research-generated evidence to support additional rulemaking.